Investigational immunotherapy drug shrinks tumors in high-risk neuroblastoma patients
Friday, June 3, 2016 - 08:20
in Health & Medicine
Investigators report promising preliminary results for an experimental monoclonal antibody when combined with chemotherapy for newly diagnosed neuroblastoma patients.